Safety and efficacy of valproate and carbamazepine in the treatment of complex partial seizures

E. L. So; C. W. Lai; J. Pellock; J. Mashman; A. Brugger

doi:10.1016/S0896-6974(05)80133-1

Safety and efficacy of valproate and carbamazepine in the treatment of complex partial seizures

E. L. So, C. W. Lai, J. Pellock, J. Mashman, A. Brugger

Neurology

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

We conducted a randomized, double-blind study of 33 patients comparing valproate (VPA) and carbamazepine (CBZ) in the treatment of complex partial seizures (CPS). Patients between the ages of 10 and 70, who had experienced at least two CPS and were previously untreated or insufficiently treated, were considered for the study. Results showed that 64% of the patients who received VPA and 64% of the patients who received CBZ were free of CPS during the 24-week maintenance period. The only significant differences in adverse events were weight gain and tremor seen in patients who received VPA. This study showed that VPA monotherapy is as effective as CBZ monotherapy in the treatment of CPS.

Original language	English (US)
Pages (from-to)	149-152
Number of pages	4
Journal	Journal of Epilepsy
Volume	5
Issue number	3
DOIs	https://doi.org/10.1016/S0896-6974(05)80133-1
State	Published - 1992

Keywords

Carbamazepine
Complex partial seizures
Drug comparison
Monotherapy
Valproate

ASJC Scopus subject areas

General Neuroscience
Clinical Neurology

Access to Document

10.1016/S0896-6974(05)80133-1

Cite this

@article{0d378c021996477ab29d58027c35236f,

title = "Safety and efficacy of valproate and carbamazepine in the treatment of complex partial seizures",

abstract = "We conducted a randomized, double-blind study of 33 patients comparing valproate (VPA) and carbamazepine (CBZ) in the treatment of complex partial seizures (CPS). Patients between the ages of 10 and 70, who had experienced at least two CPS and were previously untreated or insufficiently treated, were considered for the study. Results showed that 64% of the patients who received VPA and 64% of the patients who received CBZ were free of CPS during the 24-week maintenance period. The only significant differences in adverse events were weight gain and tremor seen in patients who received VPA. This study showed that VPA monotherapy is as effective as CBZ monotherapy in the treatment of CPS.",

keywords = "Carbamazepine, Complex partial seizures, Drug comparison, Monotherapy, Valproate",

author = "So, {E. L.} and Lai, {C. W.} and J. Pellock and J. Mashman and A. Brugger",

note = "Funding Information: Acknowledgment: This work was supported by Abbott Laboratories, Abbott Park, IL, U.S.A.",

year = "1992",

doi = "10.1016/S0896-6974(05)80133-1",

language = "English (US)",

volume = "5",

pages = "149--152",

journal = "Journal of Epilepsy",

issn = "0896-6974",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Safety and efficacy of valproate and carbamazepine in the treatment of complex partial seizures

AU - So, E. L.

AU - Lai, C. W.

AU - Pellock, J.

AU - Mashman, J.

AU - Brugger, A.

N1 - Funding Information: Acknowledgment: This work was supported by Abbott Laboratories, Abbott Park, IL, U.S.A.

PY - 1992

Y1 - 1992

N2 - We conducted a randomized, double-blind study of 33 patients comparing valproate (VPA) and carbamazepine (CBZ) in the treatment of complex partial seizures (CPS). Patients between the ages of 10 and 70, who had experienced at least two CPS and were previously untreated or insufficiently treated, were considered for the study. Results showed that 64% of the patients who received VPA and 64% of the patients who received CBZ were free of CPS during the 24-week maintenance period. The only significant differences in adverse events were weight gain and tremor seen in patients who received VPA. This study showed that VPA monotherapy is as effective as CBZ monotherapy in the treatment of CPS.

AB - We conducted a randomized, double-blind study of 33 patients comparing valproate (VPA) and carbamazepine (CBZ) in the treatment of complex partial seizures (CPS). Patients between the ages of 10 and 70, who had experienced at least two CPS and were previously untreated or insufficiently treated, were considered for the study. Results showed that 64% of the patients who received VPA and 64% of the patients who received CBZ were free of CPS during the 24-week maintenance period. The only significant differences in adverse events were weight gain and tremor seen in patients who received VPA. This study showed that VPA monotherapy is as effective as CBZ monotherapy in the treatment of CPS.

KW - Carbamazepine

KW - Complex partial seizures

KW - Drug comparison

KW - Monotherapy

KW - Valproate

UR - http://www.scopus.com/inward/record.url?scp=0026646507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026646507&partnerID=8YFLogxK

U2 - 10.1016/S0896-6974(05)80133-1

DO - 10.1016/S0896-6974(05)80133-1

M3 - Article

AN - SCOPUS:0026646507

SN - 0896-6974

VL - 5

SP - 149

EP - 152

JO - Journal of Epilepsy

JF - Journal of Epilepsy

IS - 3

ER -

Safety and efficacy of valproate and carbamazepine in the treatment of complex partial seizures

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this